These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 3062642)
1. Parabens as antimicrobial preservatives in creams. Turakka L; Ojanen T; Henell U; Karjalainen A Pharmazie; 1988 Oct; 43(10):701-3. PubMed ID: 3062642 [TBL] [Abstract][Full Text] [Related]
2. [Microbiological purity of pharmaceutical preparation. Part 2: External remedies; the effects of antimicrobial agents in various contaminated creams (author's transl)]. Melichar M; Podstatová H; Pokorný J Pharmazie; 1980; 35(9):547-9. PubMed ID: 7433506 [TBL] [Abstract][Full Text] [Related]
3. [Interactions between parabens and dermatologically important antifungal drugs (author's transl)]. Raab W; Högl F Mykosen; 1980 Aug; 23(8):442-51. PubMed ID: 6999344 [No Abstract] [Full Text] [Related]
4. [The antimicrobial effectiveness of various preservatives, alone or in combination, in creams and hydrophilic gels. I. Choice of preservatives]. Favet J; Griffiths W; Amacker PA; Schorer E Pharm Acta Helv; 1983; 58(7):178-88. PubMed ID: 6889407 [No Abstract] [Full Text] [Related]
6. [Use of the kinetics of bactericidal effect of Kathon CG on known germs in order to determine its efficacy in water and in heparin hydrophilic cream]. Favet J; Griffiths W; Amacker PA; Schorer E Pharm Acta Helv; 1985; 60(3):83-91. PubMed ID: 3991749 [No Abstract] [Full Text] [Related]
8. Studies on the evaluation of preservative efficacy--II. The determination of antimicrobial characteristics of benzylalcohol. Karabit MS; Juneskans OT; Lundgren P J Clin Hosp Pharm; 1986 Aug; 11(4):281-9. PubMed ID: 3531242 [TBL] [Abstract][Full Text] [Related]
9. [Studies on the preservatives, especially, on the antimicrobial spectra of 46 kinds of preservatives]. Ishizeki C Eisei Shikenjo Hokoku; 1971; 89():140-3. PubMed ID: 5170079 [No Abstract] [Full Text] [Related]
10. Determination of antimicrobial preservatives in pharmaceutical formulations using reverse-phase liquid chromatography. Radus TP; Gyr G J Pharm Sci; 1983 Mar; 72(3):221-4. PubMed ID: 6842372 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial preservative effectiveness of natural peptide antibiotics. Kamysz W; Turecka K Acta Pol Pharm; 2005; 62(5):341-4. PubMed ID: 16459482 [TBL] [Abstract][Full Text] [Related]
12. Degradation of parabens by Pseudomonas beteli and Burkholderia latens. Amin A; Chauhan S; Dare M; Bansal AK Eur J Pharm Biopharm; 2010 Jun; 75(2):206-12. PubMed ID: 20206257 [TBL] [Abstract][Full Text] [Related]
14. [Low-level challenge test for the examination of the microbiological susceptibility, during the period of use, of liquid and semi-solid dosage forms in multiple-dose containers (author's transl)]. Urban S; Hecker W; Schiller I Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 172(6):478-84. PubMed ID: 7257652 [TBL] [Abstract][Full Text] [Related]
15. Resistance of a strain of Pseudomonas cepacia to esters of p-hydroxybenzoic acid. Close JA; Neilsen PA Appl Environ Microbiol; 1976 May; 31(5):718-22. PubMed ID: 1275493 [TBL] [Abstract][Full Text] [Related]
16. The test for the effectiveness of antimicrobial preservation of pharmaceuticals. 3rd joint report of the Committee of Official Laboratories and Drug Control Services and the Section of Industrial Pharmacists--FIP June 1979. Pharm Acta Helv; 1980; 55(2):40-9. PubMed ID: 7384157 [No Abstract] [Full Text] [Related]
17. Antimicrobial effect of 4-hydroxybenzoic acid ester with glycerol. Kosová M; Hrádková I; Mátlová V; Kadlec D; Šmidrkal J; Filip V J Clin Pharm Ther; 2015 Aug; 40(4):436-40. PubMed ID: 26012359 [TBL] [Abstract][Full Text] [Related]
18. Preservation of pharmaceuticals by the ampholyte dodecyldi-(aminoethyl)glycine. Pilling M; Brown MW; Ford JL Pharm Acta Helv; 1987; 62(3):73-80. PubMed ID: 3588642 [No Abstract] [Full Text] [Related]
19. Are the vascular effects of naloxone attributable to the preservatives methyl- and propylparaben? Brandt L; Andersson KE; Hindfelt B; Ljunggren B; Pickard JD J Cereb Blood Flow Metab; 1983 Sep; 3(3):395-8. PubMed ID: 6874744 [TBL] [Abstract][Full Text] [Related]
20. Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques. Gupta S; Kaisheva E AAPS PharmSci; 2003; 5(2):E8. PubMed ID: 12866935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]